AbbVie, Amgen and Takeda jointly study impact of anti-inflammatory drugs in COVID-19 treatment
I-SPY COVID will evaluate the impact of cenicriviroc, otezla, and firazyr on inflammatory response in severely ill, hospitalised…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Firazyr
Cipla receives final approval for generic version of Shire’s Firazyr
Icatibant injection is indicated for the treatment of acute attacks of hereditary angioedema (HAE) in adults 18 years of age and…